All posts by imreal

LUDWIG+ Launches THX Campaign to Show Appreciation to Healthcare Workers


#THXfrontline

LUDWIG+, a full-service, woman-owned marketing agency, is launching THX, a multifaceted media campaign designed to show the community’s appreciation to the front line hospital workers who are risking their lives to care for patients infected with COVID-19.

The LUDWIG+ team created a unique logo that incorporates the universal hospital “H” symbol flanked by a T and X to form “THX”, a shorthand version of “thanks”. They are encouraging users to share #thx and #thxfrontline on Facebook, Twitter, Instagram and LinkedIn while tagging the hospital workers they want to recognize. LUDWIG+ also wants people to print the THX graphic at home and hang it in their front windows, as well as add a frame to their Facebook profiles to show support.

“We’re so grateful to the doctors, nurses and other healthcare workers who are risking their own health and safety to care for the sickest among us,” said Barbara Yolles, owner and CEO of LUDWIG+. “While we can never repay these workers for their sacrifices, we can do our part to show our appreciation. Our hope is that this campaign helps lift the spirits of these selfless heroes.”

As part of the campaign, LUDWIG+ has also teamed up with WDIV-TV’s food4frontline to provide free meals to metro-Detroit healthcare workers, which helps to both feed those on the front lines and support local businesses that have been heavily impacted by mass closures. Supporters can also purchase THX t-shirts for $20 and sweatshirts for $35—with all proceeds going to food4frontline.

According to media reports, at least 5,400 doctors, nurses and other healthcare workers have been infected with COVID-19, and dozens have died from the disease.

For more information on the THX campaign, visit: http://www.thxfrontline.com.

About LUDWIG+

LUDWIG+ is a full-service, women-owned marketing partner that excels in mind-blowing digital technology, infectious social media, brilliant strategic planning, laser-focused media planning, efficient media buying, insightful analytics, and wicked-good creative that contains all those valuable keywords, like the ones found in this long run-on sentence, to drive SEO/SEM. LUDWIG+ is headquartered in Metro Detroit. For more information, go to LUDWIG+

###

Share article on social media or email:

ATIV Software Releases EventPilot® Virtual Event App for Virtual Meetings


“The EventPilot Virtual App ties everything together so you provide your attendees with one location to manage everything they need to do,” says Silke Fleischer, CEO at ATIV Software

ATIV Software today announced the release of the EventPilot Virtual Event App, a meeting platform designed to be the central hub for virtual conferences. The EventPilot platform makes the transition to virtual events easy for meeting planners and event organizers. It offers the option to integrate recordings, live virtual sessions, webinars, and ePosters accessible to registered attendees.

With the EventPilot platform, event organizers can offer their attendees a central and comprehensive solution specifically designed for medical and scientific events. Complex event programs with dozens of concurrent sessions and many hundreds of poster presentations are converted into virtual meetings and perfectly managed by the EventPilot system. At the same time, the EventPilot Virtual Event App with a desktop component ensures virtual event attendees can join with the device of their choice. Content and virtual session access is seamless.

“The EventPilot Virtual App ties everything together so you provide your attendees with one location to manage everything they need to do,” says Silke Fleischer, CEO at ATIV Software. “And the physical experience can be translated into the app in a myriad of virtual networking and discussion capabilities.”

Features and benefits of the EventPilot Virtual Event App include:

  • Automatic program conversion to virtual meeting including maintenance and virtual host license management.
  • Attendees can participate in virtual sessions, webinars, poster presentations and recordings directly from the mobile virtual event app or desktop itinerary planner within the platform.
  • Exhibitors can build out extensive profiles including website, PDF, and video links for their virtual swag bag or include a virtual conference booth to connect face-to-face with attendees.
  • Maximize sponsorship revenue through targeted advertisement placement.

Availability

The EventPilot Virtual Event App is available now. For more information on the EventPilot Virtual Event App, visit https://www.ativsoftware.com/virtual-events/.

About ATIV Software

ATIV Software supplies the leading mobile conference app for large scientific and medical meetings. Solutions include the EventPilot® conference app; ScanHunt™ gamification app, a scavenger hunt app for gamification and engagement; and RouteInside® wayfinder app, an indoor navigation app. Apps designed by ATIV Software are consistently chosen for professional, scientific conferences from as small as 200 people to over 30,000 attendees. Learn more at https://www.ativsoftware.com.

Follow us on LinkedIn: https://www.linkedin.com/company/ativ-software

Share article on social media or email:

Paul Weiss Joins Health IT Company Wambi as Chief Technology Officer


Paul Weiss joins Wambi as Chief Technology Officer

I am most excited to be a part of a team of gracious and caring individuals that are trying to make a difference in the lives of those whose job it is to make a difference in patients’ lives.

Paul Weiss joins the Wambi team as Chief Technology Officer. Weiss plans to guide Wambi’s future growth by tapping into his experience in pharmaceuticals, manufacturing, healthcare, and security, which extends back nearly a quarter of a century. Weiss has made a career out of serving as a technology liaison for business leaders to identify, design, and deliver software solutions to solve real-world problems.

Working closely with Wambi’s Co-founders, Rebecca Metter, CEO, and Alex Coren, Chief Innovation Officer, Weiss is responsible for fortifying and growing the Wambi and Carepostcard offerings to bring actionable insights and real-time recognition to healthcare workers. His responsibilities include identifying and enabling strategic feature development, software life cycle process improvement, and new technology implementation. Weiss is also responsible for the security architecture and management for Wambi products and services. “First and foremost, Paul exemplifies the Wambi values and is driven by our mission. Paul’s strong history in teambuilding, coupled with his technology and innovation expertise, make him a great fit for our Wambi family,” says Metter.

Prior to joining Wambi, Weiss co-founded Coactive, a workflow and business automation company; designed software solutions; and consulted for Big Pharma companies like Lilly, Amgen, and Pfizer in the U.S., Puerto Rico, Canada, Europe, and Asia. Weiss is an ongoing student of industry, gaining certifications and training to serve his own goals and the goals of the companies under which he’s served, such as the Scrum Master and Certified Scrum Product Owner certifications.

When asked where his passion in healthcare originated, Weiss explains, “My sister and her husband are medical doctors. My mother, mother-in-law, and sister-in-law are nurses. I have seen first-hand the difficulty of working on the frontlines in healthcare. My hope is to help restore passion to these real-life heroes through professional recognition via the Wambi and Carepostcard platforms.”

Weiss specializes in building high-performing, motivated teams. “I am most excited to be a part of a team of gracious and caring individuals that are trying to make a difference in the lives of those whose job it is to make a difference in patients’ lives.” 

Follow the Gratitude

Facebook

Twitter

Instagram

LinkedIn

About Wambi

Wambi is the only real-time patient-driven and peer-to-peer recognition and gratitude platform. Its gamified approach increases employee engagement, reduces clinician burnout, and enhances the patient experience. Wambi gives flight to the personal side of healthcare by surfacing the moments where a human connection makes all the difference, connecting patients and team members and improving the human experience for all. Learn more at http://www.wambi.org.

Share article on social media or email:



AssuredPartners Announces Acquisition of Transportation Insurance Advisors, LLC


News Image

“We have found that TIA Advisors values and principals align with our vision and we are delighted to form our new partnership. We welcome the clients and staff to AssuredPartners,” stated AssuredPartners President and COO Tom Riley.

AssuredPartners, Inc. is pleased to announce the acquisition of Transportation Insurance Advisors, LLC located in Sanford, FL. The team of 55 will remain under the operational leadership of Scott Light, in addition, the agency currently reports $14 million in annualized revenues.

“Transportation Insurance Advisors (TIA Advisors) is more than an insurance provider, we are a business advisor who guides trucking companies all over the nation in sound business decisions. We give clients a road map that takes their businesses down the path of success,” stated Scott Light. “Our partnership with AssuredPartners will allow us to continue to deliver the highest level of service with the best solutions our clients expect from us.”

AssuredPartners Regional President Jack Suber stated, “Having TIA Advisors join AssuredPartners is a fantastic fit for our National Trucking Practice. TIA Advisors will be a great asset to our continued growth. This group of specialized brokers is fully dedicated to the trucking industry and has developed strong business connections with the best carriers in the country.”

“At AssuredPartners we’re not just in the insurance business, we are in the business of developing strong, lasting relationships. We have found that TIA Advisors values and principals align with our vision and we are delighted to form our new partnership,” stated AssuredPartners President and COO Tom Riley. “We welcome the clients and staff to AssuredPartners.”

For more information on Transportation Insurance Advisors, LLC, please visit: tiadvisors.net

ABOUT ASSUREDPARTNERS, INC

Headquartered in Lake Mary, Florida and led by Jim Henderson and Tom Riley, AssuredPartners, Inc. acquires and invests in insurance brokerage businesses (property and casualty, employee benefits, surety and MGU’s) across the United States and in London. From its founding in March of 2011, AssuredPartners has grown to over $1.5 billion in annualized revenue and continues to be one of the fastest growing insurance brokerage firms in the United States with over 180 offices in 30 states and London. For more information, please contact Dean Curtis, CFO, at 407.708.0031 or dean.curtis@assuredpartners.com, or visit http://www.assuredpartners.com.

Share article on social media or email:

CMI/Compas, Through Its Partnership with HRS Consulting, is Part of the $1 Billion VHA Integrated Healthcare Transformation (IHT) Prime Contract Award


This contract supports the programmatic and transformation needs of VHA, including the Office of Healthcare Transformation and its customers, to best accomplish VHA’s mission, strategic goals, healthcare priorities, and initiatives.

CMI/Compas will support all media-related activities as part of a Veteran Health Administration (VHA) contract awarded to HRS Consulting Inc. by the Department of Veterans Affairs (VA) to provide best value healthcare and professional consulting services. CMI/Compas provides media strategy, planning, innovation and buying for the nation’s top healthcare companies and is part of WPP.

Through the IHT vehicle, HRS will assist with completion of an organizational transformation that enhances VHA’s capabilities to provide seamless, high-quality, integrated, coordinated healthcare, anytime and anywhere, by focusing on health system transformation and innovation, implementation and operations support, and healthcare business enabling services.

About the Contract: The VHA Office of Healthcare Transformation (OHT) and the Strategic Acquisition Center- Frederick (SAC-F) collaborated to put in place a ten-year multiple-award Indefinite-Delivery Indefinite-Quantity (IDIQ) contract. This contract supports the programmatic and transformation needs of VHA, including the Office of Healthcare Transformation and its customers, to best accomplish VHA’s mission, strategic goals, healthcare priorities, and initiatives. The VHA IHT agreement has a collective ceiling of $1 Billion, and a period of performance of a 5-year base and one 5-year option.

The company delivers game-changing media performance and precision solutions to clients, fueled by talent, data, technology and amplification of creative. CMI/Compas also recently announced the creation of a growth & innovation practice, part of an overall strategy to continue strong growth and innovation.

CMI/Compas has brought many firsts to healthcare marketing as the leading healthcare-focused media buying and planning resource to the world’s game changers in pharma and life sciences.

About CMI/Compas

Well-known as a media planning and buying organization for healthcare clients, sister agencies CMI Media, a WPP company, and Compas, Inc. together form the indispensable strategic marketing partner to the world’s game-changers in health, offering guidance at every level of marketing. CMI/Compas focuses on core service offerings of Audience Strategy and Non-Personal Promotion Strategy, Planning, Buying, and Customer Insights and performance management/precision analytics. With continuous investment in the things that really matter, CMI and Compas have achieved unsurpassed tenure of healthcare marketing talent, clients and suppliers. CMI/Compas has eight offices across the US. https://cmimedia.com/

Share article on social media or email:

Aniara Diagnostica would like to announce the availability of Biophen™ FXIII


News Image

The entire Aniara line is available for purchase at http://www.aniara.com.

Aniara Diagnostica is pleased to announce the availability of Biophen™ FXIII chromogenic method for determination of FXIII.

Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.

For Research Use Only. Not for Use in Diagnostic Procedures.

BIOPHEN™ Factor XIII kit is a chromogenic method proposed for in vitro quantitative determination of Factor XIII activity in human citrated plasma.

227005 Biophen™ FXIII click here for more information.

The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.

Share article on social media or email:

Vero Naturals to Provide Free Green CBD Powder to Organizations and Brands Conducting Case Studies on COVID-19 Related Mental Health Disorders


Vero Naturals, an innovative business to business ingredient provider of the world’s first Nano green cannabinoids, is offering free Green CBD (gCBD) to consumer brands and universities interested in conducting case studies surrounding the rise of anxiety and other mental illnesses due to the COVID-19 pandemic.

Distribution of the free gCBD will be given to organizations and brands whose case studies focus on the development of products or research that can potentially help with symptoms associated with anxiety, stress, post traumatic stress disorder and other mental illnesses resulting from the current public health emergency. According to a recent survey by the Kaiser Family Foundation, 45% of individuals say COVID-19 related stress is affecting their mental health. Additionally, a crisis and mental health service hotline has seen an astonishing 891% increase in calls from this time last year. Both findings demonstrate the severe impact COVID-19 has had on Americans as well as the effects the crisis has on mental health and wellbeing.

“Affecting 40 million adults, anxiety is the most common mental illness in the U.S., and as this crisis continues, the stress of millions losing their jobs and thousands getting sick has surely created an uptick in this number that will continue,” said Vero Naturals President and Co-Founder, Rory Millikin, “We want to offer gCBD for case studies at no cost to brands and organizations to together determine if CBD can be helpful in combating anxiety and other mental health issues. I expect a sharp spike in these issues due to the COVID-19 environment that we now find ourselves in, and partnerships like these have the potential to make a difference in the health and wellness of many.We hope our innovative product could help provide the solutions many people are seeking during these uncertain times and beyond.”

Previous studies regarding CBD and mental health have shown that the compound is effective in reducing symptoms for a variety of disorders, including anxiety. Vero has patented a particle reduction process that uses only natural forces which, for the first time, captures all of the hemp plant’s extraordinary properties. Unlike commonly used CO2 extraction processes that only capture a portion of the hemp plants more than 500 compounds, Vero’s particle reduction process in turn reduces the entire plant, resulting in the most effective Entourage Effect possible.The company’s gCBD is 100 percent naturally-produced, using no harmful heat, carbon dioxide or strip mining chemicals during the process. The result is a clean, green-colored CBD powder that can easily be added to natural, better-for-you foods, beverages, beauty products and be tested in labs for various studies.

“I have used Vero’s completely unique gCBD in multiple case studies to date, including one related to hair regrowth and another that was used in determining consistent and concentrated presence of gCBD in the bloodstream compared to extracted forms of CBD,” said leading CBD expert, Harvard University graduate, author and former United States Army Medic, Dr. Gregory Smith, “The results were extremely impressive and leads me to believe that this innovative gCBD acts very differently than extracted CBD and is more effective. I am very interested to see how it performs in other studies or trials.”

Vero Naturals Green CBD is currently used in popular consumer brands such as Kopari Beauty which is available at Ulta nationwide and has already seen large success and outstanding feedback from customers that entrust the products and brands to offer them unique products made with real ingredients like Vero Naturals.

Brands interested in partnering with Vero Naturals to create their clinical trial are invited to get in touch via email a rory@veronaturals.com. Limited quantities of free GCBD are available and the amount will be determined upon consultation. For more information on Vero Naturals please visit http://www.veronaturals.com.

###

About Vero Naturals

Vero Naturals is an ingredient supplier to brands that has created the first B2B green Nano CBD Powder and Liposomes in the market. Vero Naturals has both patents issued and over 20 pending in a multitude of sectors within the cannabis industry. For more information, please visit http://www.veronaturals.com

Share article on social media or email:

Aeroflow Healthcare Expands Telemedicine Services During COVID-19 Pandemic


Aeroflow Healthcare continuously looks for solutions to patients’ problems and ultimately improve health outcomes, and implementing this expansion of telehealth services helps us solve major issues that many patients are experiencing during these challenging times.

Aeroflow Healthcare, a nationwide medical equipment (DME) provider, announced an expansion of sleep apnea treatment solutions during the COVID-19 pandemic, including the addition of telemedicine services.

Aeroflow is contracting with Itamar Medical, a medical technology company focused on the development and commercialization of non-invasive medical devices, solutions and a digital health platform to aid in the diagnosis of respiratory sleep disorders. This relationship will increase patient access to home sleep testing using the WatchPATtm ONE single use device for sleep apnea, allowing patients to manage their sleep apnea treatment and improve their health outcomes as patients and providers alike are asked to stay home to slow the spread of COVID-19.

Aeroflow will facilitate telehealth consultations with board-certified physicians for sleep data interpretations and diagnosis, while Aeroflow respiratory therapists will provide in-home and telehealth respiratory therapy set-ups.

“Implementing telehealth services enables our patients to get the highest quality care possible during a very difficult time,” said Michelle Worley, Director of Clinical Operations at Aeroflow Healthcare’s Sleep division. “Patient care continues to be the top priority of our clinical staff, and this expansion allows them to continue serving patients uninterrupted.”

“COVID-19 may impact patients’ access to critical medical services, but Aeroflow Healthcare is committed to helping them stay safe and healthy by remaining fully operational and providing telehealth sleep therapy services,” said Eric Mongeau, National Sales Director at Aeroflow Healthcare’s Sleep division. “Aeroflow Healthcare continuously looks for solutions to patients’ problems and ultimately improve health outcomes, and implementing this expansion of telehealth services helps us solve major issues that many patients are experiencing during these challenging times.”

About Itamar Medical Ltd.

Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit http://www.itamar-medical.com.

About Aeroflow Healthcare

Aeroflow Healthcare was founded in Asheville, NC in 2001 as a home oxygen provider, and has since grown to become a nationwide provider of durable medical equipment. In 2017, Aeroflow was also awarded the HME Excellence Award for Best Home Medical Equipment Provider and has been recognized as a business offering top-notch benefits to employees with the Great Place to Work Award. Aeroflow is an accredited Medicare and Medicaid provider and accepts most commercial insurance. To learn more about Aeroflow Healthcare and getting medical equipment through insurance, visit http://www.aeroflowinc.com.

Share article on social media or email:

Baker Furnace Provides Solution for Handling Infectious Medical Waste During COVID-19 Pandemic


Baker Furnace Medical Waste Incinerator

Medical Waste Incinerator

“Our systems can be designed to process a few pounds of waste to thousands of pounds of waste. As medical waste increases during this pandemic it is important to limit the environmental impact and minimize additional landfill waste.” – Greg Jennings, President and CEO

Baker Furnace, a leading supplier of pollution control equipment, is excited to announce an incineration solution for infectious medical waste. As more and more people are treated for COVID-19, the amount of infectious waste produced will continue to increase. Baker Furnace manufactures medical waste incinerators that use temperatures in excess of 1,000° C to eliminate infectious pathogens and reduce waste.

According to preliminary data the COVID-19 virus survives longer outside the body than the common flu. The medical waste that hosts these pathogens will need to be treated at help centers and hospitals across the world. For example, medical personnel are using N95 masks throughout their shifts. These N95 masks may contain the COVID-19 virus and will need to be disposed of properly to eliminate the potential of infecting others. The sheer number of N95 masks and other PPE that are being used and disposed of creates a waste issue at medical facilities. If this waste is simply sterilized and taken to a landfill instead of incinerating, the environmental impact will be significant.

Medical waste incinerators provide an effective, environmentally friendly solution to the impending medical waste crisis. Baker Furnace specializes in pollution control equipment including waste incinerators that are used on pathological and infectious medical waste. These incinerators effectively destroy COVID-19 along with other virus by using a thermal oxidation process and heating the medical waste to extreme temperatures in excess of 1,000°C.

Baker Furnace’s medical waste incineration systems are designed in configurations that allow for them to be transported from site to site and only require an electric and gas connection. This provides facilities with the option to maximize their usage and waste reduction. A medical waste incinerator will not only eliminate the virus on waste but also reduce the amount of waste by up to 99%. This secondary benefit is important to consider because it minimizes the increase in landfill waste due to this pandemic and provides a cost savings to facilities on waste disposal services.

“Autoclaves can use steam to sterilize medical waste but there is no reduction of waste. Our systems can be designed to process a few pounds of waste to thousands of pounds of waste. As medical waste increases during this pandemic it is important to limit the environmental impact and minimize additional landfill waste.” – Greg Jennings, President and CEO

About Baker Furnace

Baker Furnace, Inc. has been designing, engineering, and manufacturing industrial ovens, pollution control equipment and other heating equipment since 1980. Their custom and standard equipment are used for a multitude of applications including heat treating, finishing, drying, and curing. Many of the industries they serve require specific temperature uniformity and equipment performance documentation. Their experienced engineering team can meet even the most stringent standards for their customers’ equipment. For more information visit http://www.bakerfurnace.com.

Baker Furnace is owned by Thermal Product Solutions (“TPS”), a leading American manufacturer of custom industrial ovens used for heat treating, finishing, drying, curing, manufacturing automation and process control. TPS is a global leader in thermal processing products and test solutions with brands including Blue M, Gruenberg, Tenney, Lindberg, Lunaire, MPH and Wisconsin Oven. For more information on equipment solutions from TPS visit the website at http://www.thermalproductsolutions.com.

Share article on social media or email:

Ripple Science Announces Initiatives for Clinical Research Teams During COVID


Ripple Science Logo

Ripple Science Logo

The fact that Ripple is web-based is a game changer for us.

Ripple Science today announced new initiatives to help clinical researchers continue their work through COVID-19. Many clinical trial teams are working remotely and have paused patient visits, forcing teams to do more of their work online. Ripple Science wants to help researchers continue their research during this uncertain time by giving research teams free access to Ripple for their first study. For those working on COVID-19 trials directly, the company is providing six months of access to Ripple free of charge.

Ripple is a web-based platform designed for clinical research teams who want a secure and streamlined way to recruit, manage, and retain patients for trials. Ripple is a purpose-built CRM and project manager which organizes clinical trial recruiting and research efforts, leading to valuable time and cost savings. Debi Gross, Community Outreach Director for Stony Brook University’s autism initiative, stated, “The fact that Ripple is web-based is a game-changer for us… The time between when participants contact us to enrolling them in a study seems a lot shorter and quicker.”

Peter Falzon, President and CEO of Ripple Science, commented, “We are committed to supporting research teams to work remotely and communicate with patients differently in response to COVID-19. Our customers have been telling us what they need and how Ripple helps, and we are responding to their needs by accelerating feature updates and expanding access.”

In the upcoming weeks, Ripple Science will release features aligned to even better support the initiatives of researchers working in this new paradigm.

About Ripple Science: Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants faster and reduces patient loss to poor follow-up. Ripple Science’s flagship product, Ripple, is used by research investigators at more than 100 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.

Share article on social media or email: